Free shipping on all orders over $ 500

Deferitrin

Cat. No. M3793
Deferitrin Structure
Synonym:

GT-56-252

Size Price Availability Quantity
5mg USD 340 In stock
10mg USD 480 In stock
50mg USD 1800 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Deferitrin is a novel, orally available iron chelator. Deferitrin may be useful as chelation monotherapy or as part of combination or doublet chelation therapy for the treatment of severe iron overload in patients with beta-thalassemia major if its favorable pharmacokinetic profile, efficacy, safety and tolerability are confirmed in more extensive clinical trials. A phase I/II clinical trial that began in September 2003 has reportedly completed recruitment. Deferitrin was safe, well-tolerated, and well-absorbed either with food and fasting in beta-thalassemia patients. Renal excretion of deferitrin uncomplexed with iron was similar to that seen in preclinical studies, which predict iron excretion to be via the fecal route. Further studies are ongoing to define the effect of deferitrin on iron balance.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 253.28
Formula C11H11NO4S
CAS Number 239101-33-8
Purity >98%
Solubility DMSO
Storage at -20°C
References

Drug evaluation: Deferitrin for iron overload disorders.
Barton JC. IDrugs. 2007 Jul;10(7):480-90. PMID: 17642018.

Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disorders.
Barton JC. IDrugs. 2007 Apr;10(4):270-81. PMID: 17390251.

Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
Donovan JM, et al. Ann N Y Acad Sci. 2005;1054:492-4. PMID: 16339704.

Related 5-HT Receptor Products
Idalopirdine hydrochloride

Idalopirdine hydrochloride is a potent and selective 5-HT6 receptor antagonist with a Ki value of 0.83 nM.

PRX-08066

PRX-08066 is a a novel 5-hydroxytryptamine receptor 2B antagonist with IC50 of 3.4 nM.

MIN-101

MIN-101 (Roluperidone) is a novel compound with affinities for 5-HT2A and sigma-2 receptors with Ki values of 7.53 nM and 8.19 nM, respectively.

GSK163090

GSK163090 is a potent, selective, and orally active 5-HT1A/B/D receptor antagonist.

Eptapirone

Eptapirone (F11440) is a potent 5HT(1A) receptor agonist with marked anxiolytic and antidepressant potential.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: Deferitrin, GT-56-252 supplier, 5-HT Receptor, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.